Effects of OPC-14523, a combined sigma and 5-HT1a ligand, on pre- and post-synaptic 5-HT1a receptors
Authors:
- 1 January 2007
- journal article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 21 (1) , 85-92
Abstract
OPC-14523 (OPC) is a novel compound with high affinity for sigma and 5-HT1A receptors that shows ‘antidepressant-like’ effects in animal models of depression. We have previously demonstrated that OPC produces an increase in 5-HT neurotransmission and a decreased response of 5-HT neurons to the acute administration of paroxetine in the DRN, an effect that appears to be mediated by OPC’s 5-HT1A receptor affinity. The current study sets out to investigate more specifically the effects of OPC on 5-HT1A pre- and post-synaptic receptors, to assess whether it acts as an agonist or antagonist. Using an electrophysiological model of in vivo extracellular recordings in anaesthetized rats, the effects of OPC was assessed on pre-synaptic DRN 5-HT1A autoreceptors and post-synaptically on hippocampal 5-HT1A receptors of CA3 pyramidal neurons. OPC applied by microiontophoresis, produced a significant decrease in the firing activity of 5-HT neurons of the DRN and of quisqualate-activated CA3 pyramidal neurons of the dorsal hippocampus. The effects of OPC on 5-HT1A receptors were significantly reduced by the co-application of the 5-HT1A antagonist WAY-100635. In addition, the effects of OPC were not blocked by the injection of the sigma antagonists NE-100 or haloperidol. Therefore, OPC is acting as an agonist on both pre- and post-synaptic 5-HT1A receptors. The current findings combined with previous data on OPC suggest a pharmacological profile that warrants further investigation.Keywords
This publication has 35 references indexed in Scilit:
- Effects of the Potential Antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone Monomethanesulfonate] a Combined σ and 5-HT1A Ligand: Modulation of Neuronal Activity in the Dorsal Raphe NucleusThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Serotonin-Induced Increases in Adult Cell Proliferation and Neurogenesis are Mediated Through Different and Common 5-HT Receptor Subtypes in the Dentate Gyrus and the Subventricular ZoneNeuropsychopharmacology, 2003
- Modulation of serotonergic neurotransmission by short‐ and long‐term treatments with sigma ligandsBritish Journal of Pharmacology, 2001
- Electrophysiological evidence for postsynaptic 5-HT1A receptor control of dorsal raphe 5-HT neuronesNeuropharmacology, 2001
- Molecular Neurobiology for Practicing Psychiatrists, Part 5: How a Leucine Zipper Can Turn On Genes: Immediate-Early Genes Activate Late-Gene Expression in the Brain.The Journal of Clinical Psychiatry, 2000
- Role of the medial prefrontal cortex in 5‐HT1A receptor‐induced inhibition of 5‐HT neuronal activity in the ratBritish Journal of Pharmacology, 1999
- Beneficial Effects of Acute and Repeated Administrations of σ Receptor Agonists on Behavioral Despair in Mice Exposed to Tail SuspensionPharmacology Biochemistry and Behavior, 1998
- Current advances and trends in the treatment of depressionTrends in Pharmacological Sciences, 1994
- The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotoninergic neurons in rats is attenuated by lesion of the frontal cortexNeuropharmacology, 1994
- A proposal for the classification of sigma binding sitesTrends in Pharmacological Sciences, 1992